ANA
LLUCH HERNANDEZ
EMÉRITO/A UNIVERSIDAD
Copenhagen University Hospital
Copenhague, DinamarcaPublicacións en colaboración con investigadores/as de Copenhagen University Hospital (4)
2021
-
Selective AKT kinase inhibitor capivasertib in combination with fulvestrant in PTEN-mutant ER-positive metastatic breast cancer
npj Breast Cancer, Vol. 7, Núm. 1
2018
-
In Reply to Belkacemi and Tsoutsou
International Journal of Radiation Oncology Biology Physics
-
Postmastectomy Radiation Therapy in Women with T1-T2 Tumors and 1 to 3 Positive Lymph Nodes: Analysis of the Breast International Group 02-98 Trial
International Journal of Radiation Oncology Biology Physics, Vol. 101, Núm. 2, pp. 316-324
2015
-
Final 10-year results of the Breast International Group 2-98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancer
European Journal of Cancer, Vol. 51, Núm. 12, pp. 1481-1489